PTA Peripheral Drug Eluting Balloon Market Overview, Growth, and Trends (2021-2031)

MARKET INTRODUCTION

Percutaneous transluminal angioplasty (PTA) is widely accepted treatment for managing the symptomatic claudication and critical limb ischemia (CLI). However, when PTA is used alone it shows limitation such as high incidence of short-term restenosis. Also in-stent restenosis (ISR), thrombosis and stent fracture are widely seen as long-term complications in indwelling stents. Therefore, PTA is incorporated with drug eluting balloons as it allows homogeneous delivery of an antiproliferative drug.

MARKET DYNAMICS

The PTA peripheral drug eluting balloon market growth is estimated to grow due to increasing incidences of vascular thrombosis, and peripheral vein blockages. The market is also likely to grow due to increasing product approvals for PTA drug eluting balloons in the market. The market is expected to experience growth opportunities in the emerging regions due to growing developments in medical device industry.

MARKET SCOPE

The "PTA Peripheral Drug Eluting Balloon Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of PTA peripheral drug eluting balloon market with detailed market segmentation by application, and end user. The PTA peripheral drug eluting balloon market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in PTA peripheral drug eluting balloon market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The PTA peripheral drug eluting balloon market is segmented on the basis of, application and end user. Based on application, the market is classified as popliteal artery entrapment syndrome (PAES), and superficial femoral artery (SFA). Based on end user, the market is classified as hospitals, cath labs, and ambulatory surgical centers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the PTA peripheral drug eluting balloon market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The PTA peripheral drug eluting balloon market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting PTA peripheral drug eluting balloon market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the PTA peripheral drug eluting balloon market in these regions.

MARKET PLAYERS

The report covers key developments in the PTA peripheral drug eluting balloon market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from PTA peripheral drug eluting balloon market are anticipated to have lucrative growth opportunities in the future with the rising demand for PTA peripheral drug eluting balloon in the global market. Below mentioned is the list of few companies engaged in the PTA peripheral drug eluting balloon market.

The report also includes the profiles of key players in PTA peripheral drug eluting balloon market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

•  Boston Scientific Corporation
  
•  AnGes MG, Inc.
  
•  Acrostak Int. Distr. Sàrl
  
•  iVascular S.L.U.
  
•  Medtronic Plc
  
•  B. Braun Melsungen AG
  
•  BD
  
•  Cook Medical
  
•  Concept Medical Inc.
  
•  BIOTRONIK SE and Co. KG
  

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

PTA Peripheral Drug Eluting Balloon Report Scope